Welcome Message
 
Our Company
 
Awards & Recognition
 
Corporate Governance
 
Management Council
Board of Directors
Reports of Insider Transactions
Committee Charters
Corporate Governance Guidelines
Additional Policies and Guidelines
Codes of Conduct
Articles of Incorporation (PDF)
Bylaws (PDF)
 
Compliance & Ethics
 
Our Websites
 
Business Links

 

  » BMS.com Home » About Us » Corporate Governance
SEARCH INDEX
 




The management and Board of Directors of Bristol-Myers Squibb Company believe that operating the company in a reliable, efficient, transparent and ethical manner enhances our ability to foster sustainable growth and create value for our stockholders.

The Bristol-Myers Squibb Pledge -- the company's statement of values and principles that guides all our activities -- commits us to "the highest standard of moral and ethical behavior" and affirms our conviction that "the priceless ingredient of every product is the honor and integrity of its maker." The values and principles espoused in our Pledge, and applied in our Standards of Business Conduct and Ethics, guide every action we take and every decision we make in the course of our business practices.




[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Atripla is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2009 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

 

SEARCH INDEX